Definitive Guide to DRGS

DRGS - Global Big Pharma ETN Profile

DRGS Tracks This Index: NYSE Arca Equal Weighted Pharmaceutical Total Return Index
Description: The index is designed to track the performance of the equity securities of a cross-section of global companies involved in various phases of the development, production and marketing of pharmaceuticals.

Issuer: RBS
Structure: ETN
Expense Ratio: 0.60%
ETFdb Category: Health & Biotech Equities
ETF Home Page: DRGS
Inception: 2011-10-24
Tax Form: 1099

Asset Class: Equity
Asset Class Size: Large-Cap
Sector (General): Healthcare
Sector (Specific): Pharmaceutical
Region (General): Global
Region (Specific): Broad

Summary Data For DRGS

52 Week Lo:	$26.08	52 Week Hi:	$35.27
AUM:	$5.5 M	Shares:	0.2 M
Avg. Volume (1 Month):	671	Avg. Volume (3 Month):	645

Last Updated: 2013-05-20

Explore DRGS on ETFdb

DRGS Holdings: View DRGS holdings by asset class, sector, country and more
DRGS Fact Sheet: View DRGS's Fact Sheet
DRGS Charts: Create custom charts of DRGS
DRGS Returns: See historical performance, volatility, and dividend information
DRGS Head-To-Head: See how DRGS compares to any other ETF in terms holdings, dividends, and more
DRGS Technical Indicators: Analyze DRGS's momentum, relative strength, MACD and more
DRGS Category Report: View the Health & Biotech Equities ETFdb Category Report
DRGS Realtime Rating: See how DRGS rates against comparable ETFs in terms of expenses, historical returns, volatility, and concentration